JP2024534231A5 - - Google Patents

Info

Publication number
JP2024534231A5
JP2024534231A5 JP2024514574A JP2024514574A JP2024534231A5 JP 2024534231 A5 JP2024534231 A5 JP 2024534231A5 JP 2024514574 A JP2024514574 A JP 2024514574A JP 2024514574 A JP2024514574 A JP 2024514574A JP 2024534231 A5 JP2024534231 A5 JP 2024534231A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
polypeptide
peptide
composition according
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024514574A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534231A (ja
Filing date
Publication date
Priority claimed from CU2021000058A external-priority patent/CU24766B1/es
Application filed filed Critical
Publication of JP2024534231A publication Critical patent/JP2024534231A/ja
Publication of JP2024534231A5 publication Critical patent/JP2024534231A5/ja
Pending legal-status Critical Current

Links

JP2024514574A 2021-07-09 2022-07-07 Ck2媒介リン酸化を阻害する線状ペプチド及びそれを含む組成物 Pending JP2024534231A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU2021000058A CU24766B1 (es) 2021-07-09 2021-07-09 Péptidos lineales que inhiben la fosforilación mediada por ck2
CU2021-0058 2021-07-09
PCT/CU2022/050007 WO2023280330A1 (es) 2021-07-09 2022-07-07 Péptidos lineales que inhiben la fosforilación mediada por ck2 y composiciones que los comprenden

Publications (2)

Publication Number Publication Date
JP2024534231A JP2024534231A (ja) 2024-09-18
JP2024534231A5 true JP2024534231A5 (https=) 2025-05-23

Family

ID=83080989

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024514574A Pending JP2024534231A (ja) 2021-07-09 2022-07-07 Ck2媒介リン酸化を阻害する線状ペプチド及びそれを含む組成物

Country Status (11)

Country Link
US (1) US20240317827A1 (https=)
EP (1) EP4368710A1 (https=)
JP (1) JP2024534231A (https=)
KR (1) KR20240032882A (https=)
CN (1) CN117795064A (https=)
AR (1) AR126388A1 (https=)
AU (1) AU2022308094A1 (https=)
CA (1) CA3225387A1 (https=)
CU (1) CU24766B1 (https=)
MX (1) MX2024000542A (https=)
WO (1) WO2023280330A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118290537B (zh) * 2024-05-09 2025-02-07 永州中古生物技术有限公司 一种在nci-h460细胞系中对ck2起到抑制作用的多肽

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23225A1 (es) 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
WO2006020207A2 (en) * 2004-07-19 2006-02-23 University Of Cincinnati Compounds for control of appetite
CA2629751A1 (en) * 2004-11-12 2006-05-18 The University Of British Columbia Antimicrobial peptides

Similar Documents

Publication Publication Date Title
JP2020023567A5 (https=)
JP2020120689A5 (https=)
JP2001520238A5 (https=)
JP2024178382A5 (https=)
CN103118699B (zh) 白介素-22在治疗病毒性肝炎中的应用
JP2020203894A5 (https=)
WO2001010457A2 (en) Pharmaceutical compositions containing tripeptides
JP2022500078A5 (https=)
JP2023071670A5 (https=)
JP2006506942A5 (https=)
JP2005527547A5 (https=)
EP1079849B1 (en) Use of hmg proteins for the preparation of medicaments having cytotoxic activity
JP2024534231A5 (https=)
JP2021514354A5 (https=)
WO2023123722A1 (zh) 一种抗冠状病毒的多肽、其衍生物及其应用
JP2024525213A5 (https=)
JP2022551813A5 (https=)
JP6721419B2 (ja) エズリン由来ペプチド、およびその医薬組成物
WO1994015634A9 (en) Tat and rev oligopeptides in hiv treatment
JP2020117504A5 (https=)
JP2023531496A5 (https=)
AU2006257286B2 (en) Uses of recombinant super-compound interferons
CN112390884B (zh) Semaphorin7A单克隆抗体及其在制备用于治疗炎症疾病药物方面的应用
RU2024102457A (ru) Линейные пептиды, ингибирующие ck2-опосредованное фосфорилирование, и содержащие их композиции
WO2021209992A1 (en) Compositions and methods for treating infectious diseases